https://www.selleckchem.com/pr....oducts/iruplinalkib.
ed asset to be used in future COVID-19 pandemic waves and other environments. ClinicalTrials.gov NCT04326400; https//clinicaltrials.gov/ct2/show/NCT04326400. ClinicalTrials.gov NCT04326400; https//clinicaltrials.gov/ct2/show/NCT04326400.[This corrects the article DOI .]. The outbreak of COVID-19 has profoundly influenced people's lifestyles; these impacts have varied across subgroups of people. The pandemic-related impacts on the health outcomes of people with dermatological conditions are unknown. The aim of this paper was to stud
Curtir
Comentario
Compartilhar
